Canine Skin Tumours: Welfare Management in Senior Dogs

Skin tumours are common in senior dogs and range from benign lipomas to malignant mast cell tumours, with welfare implications depending on location, behaviour, and management.

Key Facts

Skin tumours are the most common tumours in dogs; around a third of all dog tumours are cutaneous
Mast cell tumours are the most common malignant skin tumour in dogs, accounting for 15-20% of skin neoplasms
Some breeds including Boxers, Labradors, and Golden Retrievers have higher tumour prevalence
Not all skin lumps require surgical removal; fine needle aspiration allows cytological assessment
Aggressive mast cell tumours can metastasise to lymph nodes and internal organs, requiring staging and aggressive treatment

Welfare Considerations

Skin tumour welfare in dogs depends heavily on tumour type and location. Benign lipomas cause minimal welfare impact unless they reach sizes that impair movement. Mast cell tumours can cause local inflammation, ulceration, and if manipulated, can release histamine causing systemic effects. High-grade malignant tumours cause escalating welfare burdens as they grow and metastasise. Welfare-focused management requires accurate tumour typing before treatment planning, appropriate pain management before and after surgical procedures, and honest quality of life assessment for dogs with metastatic disease. Many senior dogs with skin tumours can maintain excellent quality of life with appropriate management for extended periods.

What You Can Do

Have any new lumps or bumps on your dog assessed by a veterinarian rather than monitoring at home
Do not squeeze or manipulate skin lumps as mast cell tumours can release inflammatory mediators
Discuss fine needle aspiration as a minimally invasive first diagnostic step for skin masses
Work with an oncology-experienced vet for mast cell tumours to develop the most welfare-appropriate treatment plan